THE 60-SECOND GUIDE
BPC-157
Observational preprint; controlled efficacy not established.
Guide prepared November 13, 2026 · profile review dates retained
What is it?
BPC-157 is an experimental 15-amino-acid peptide promoted for tissue repair and gastrointestinal complaints. Animal findings and human reports have attracted attention, but they have not established reliable clinical benefit or long-term safety. [1]
Potential benefits
A 2026 clinical-note preprint described documented use and reported experiences; its observational design cannot establish efficacy. Animal models report effects across gastrointestinal and injury pathways. Mechanistic work has generated hypotheses about vascular and tissue responses. [1]
Evidence & its limits
The 2026 clinical-note preprint had no control group or objective measurement of symptom improvement. Reported benefit cannot establish causation, and recorded adverse events cannot establish their true frequency. Small pilot reports do not resolve these gaps. [1]
Risks & unknowns
Controlled human evidence has not established broad healing claims. Passive reports cannot estimate true adverse-event frequency. Unapproved products add identity, sterility, contamination and labeling risks. WADA prohibits BPC-157. Long-term safety remains unresolved. [1]
Status & scope
BPC-157 is not FDA-approved; a July 2026 advisory-committee recommendation on compounding was nonbinding and was not a drug approval. Unapproved products create identity, sterility, contamination, and labeling risks; WADA prohibits it. [1]
The question to ask
Does the evidence match the exact product, route, condition and outcome being discussed? Check the full record and its review dates. This summary is selective; the product label and clinical assessment contain additional warnings and contraindications.
CHECK THE RECORD
Sources & review
- Full evidence record, references and review dates
- FDA bulk-substance safety page
- Clinical-note observational preprint · September 7, 2026
- Reuters · adoption, adverse-event reports, and compounding context · September 15, 2026
Guide prepared November 13, 2026 · profile review dates retained. Condensed from the linked site evidence record. This format update is not a new clinical review of every source. Consult the full profile for its evidence-review dates and targeted updates.
Selective educational summary, not treatment or dosing advice. Existing profile review dates retained; no independent clinical review.